Birch Run Capital Advisors, LP Nevro Corp Transaction History

Birch Run Capital Advisors, LP

  • $0
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Feb 14, 2020
SELL
$76.41 - $117.54 $1.94 Million - $2.99 Million
-25,425 Closed
0 $0
Q3 2019

Nov 14, 2019
SELL
$61.52 - $91.1 $3.63 Million - $5.37 Million
-59,000 Reduced 69.88%
25,425 $2.19 Million
Q2 2019

Aug 14, 2019
SELL
$58.04 - $66.99 $5.98 Million - $6.9 Million
-103,000 Reduced 54.96%
84,425 $5.47 Million
Q1 2019

May 15, 2019
BUY
$35.52 - $62.62 $6.66 Million - $11.7 Million
187,425 New
187,425 $11.7 Million

Others Institutions Holding NVRO

# of Institutions
151
Shares Held
39.3M
Call Options Held
67.9K
Put Options Held
1.59M
View Full List

About NEVRO CORP

NVRO Quotes by TradingView
  • Ticker NVRO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 35,387,800
  • Market Cap $162M
  • Description
  • Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...
More about NVRO
Track This Portfolio

Track Birch Run Capital Advisors, LP Portfolio

Follow Birch Run Capital Advisors, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Birch Run Capital Advisors, LP, based on Form 13F filings with the SEC.

News

Stay updated on Birch Run Capital Advisors, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email